COMPARATIVE-EVALUATION OF THE AMINOGLYCOSIDE ANTIBIOTICS FOR SYSTEMIC USE

被引：12

作者：

BURKLE, WS

机构：

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1981年 / 15卷 / 11期

关键词：

D O I：

10.1177/106002808101501102

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：847 / 862

页数：16

共 172 条

[1] ALTMANN G, 1970, ISRAEL J MED SCI, V6, P683
[2] [Anonymous], 1973, JAMA-J AM MED ASSOC, V224, P515
[3] PERITONEAL TRANSFER OF KANAMYCIN AND ITS USE IN PERITONEAL-DIALYSIS
ATKINS, RC
MION, C
DESPAUX, E
VANHAI, N
JULIEN, C
MION, H
[J]. KIDNEY INTERNATIONAL, 1973, 3 (06) : 391 - 396
[4] PREDICTABILITY OF BLOOD-LEVELS OF GENTAMICIN IN MAN
BARZA, M
BROWN, RB
SHEN, D
GIBALDI, M
WEINSTEIN, L
[J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (02) : 165 - 174
[5] WHY MONITOR SERUM LEVELS OF GENTAMICIN
BARZA, M
LAUERMANN, M
[J]. CLINICAL PHARMACOKINETICS, 1978, 3 (03) : 202 - 215
[6] TOBRAMYCIN IN RENAL IMPAIRMENT
BECHTOL, LD
BLACK, HR
[J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 269 (03) : 317 - 321
[7] TOBRAMYCIN SULFATE - SUMMARY OF WORLDWIDE EXPERIENCE FROM CLINICAL-TRIALS
BENDUSH, CL
WEBER, R
[J]. JOURNAL OF INFECTIOUS DISEASES, 1976, 134 : S219 - S234
[8] BENNETT WM, 1977, J LAB CLIN MED, V90, P389
[9] BLACK RE, 1976, ANTIMICROB AGENTS CH, V9, P956, DOI 10.1128/AAC.9.6.956
[10] TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS
BLOUIN, RA
MANN, HJ
GRIFFEN, WO
BAUER, LA
RECORD, KE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) : 508 - 512